Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Interim Management Statement

18 Nov 2013 14:35

RNS Number : 3098T
Maven Income & Growth VCT 4 PLC
18 November 2013
 

Interim Management Statement

 

Maven Income and Growth VCT 4 PLC (the Company) - quarter ended 30 September 2013

 

This Interim Management Statement, for the quarter ended 30 September 2013, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 October 2013 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

· Net asset value (NAV)1 of 96.00p per Ordinary Share and 101.01p per C Share at 30 September 2013, after payment of the interim dividend on the Ordinary Shares, compared to 97.60p and 98.40p per share respectively at 30 June 2013;

· NAV total return2 of 125.3p per Ordinary Share at 30 September 2013, compared to 124.9p at 30 June 2013; and

· Interim dividend of 2.00p per Ordinary Share in respect of the year ending 31 December 2013, paid on 27 September 2013.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 30 September 2013. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 30 June 2013, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 30 September 2013, a net amount of £139,826 was invested from the Ordinary Share portfolio in two unlisted companies; net proceeds of £402,967 were realised from the sale of short-dated UK treasury bills; a total of £432,553 of capital was returned from three unlisted companies against a cost of £508,811 and the full or partial disposals of four AIM quoted investments generated aggregate proceeds of £115,584 against a total cost of £103,855.

 

During the same period, the full or partial disposals of three AIM quoted investments from the C Share portfolio, generated aggregate proceeds of £48,118 against a total cost of £29,277.

 

3.

Recent developments

 

Between 1 October 2013 and the date of this Statement, £132,769 was invested in two unlisted companies; a total of £295,254 of capital was returned by two unlisted companies; and the partial disposal of an AIM quoted investment generated proceeds of £35,438 against a cost of £32,284.

 

In the same period, an investment of £112,000 in an unlisted company was made on behalf of the C Share portfolio and the sale of the unlisted investment in Espresso Group generated proceeds of £1,246,191. While the reduction of £253,809 against the carrying value of Espresso Group represents 6.5% of the net assets attributable to the C shares as at 30 September 2013, the Manager has taken the view that this was the optimum opportunity to secure an exit from a legacy investment acquired from the merger of the Company with Ortus VCT PLC earlier in 2013.

 

Other than as described above, and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 July 2013 to 30 September 2013, or in the period from 1 October 2013 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

18 November 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUWOSROOAAAAA
Date   Source Headline
20th May 202610:12 amRNSAdmission of Further Securities to Trading
15th May 202610:45 amRNSDirector/PDMR Shareholding
15th May 202610:41 amRNSIssue of Equity - Dividend Investment Scheme
14th May 20265:22 pmRNSTransaction in Own Shares
12th May 20263:37 pmRNSUnaudited NAV - Dividend Investment Scheme
7th May 20261:45 pmRNSResult of AGM
30th Apr 202610:58 amRNSAdmission of Further Securities to Trading
29th Apr 202612:29 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:27 amRNSAdmission of Further Securities to Trading
14th Apr 202611:09 amRNSIssue of Equity
10th Apr 202612:02 pmRNSUnaudited Net Asset Value
8th Apr 20269:33 amRNSAdmission of Further Securities to Trading
25th Mar 20263:51 pmRNSTransaction in Own Shares
25th Mar 202610:55 amRNSAdmission of Further Securities to Trading
24th Mar 202612:11 pmRNSIssue of Equity
19th Mar 20264:21 pmRNSUnaudited NAV and Proposed Final Dividend
18th Feb 20264:58 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202610:54 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:07 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:52 amRNSDirector/PDMR Shareholding
16th Jan 20269:44 amRNSIssue of Equity
15th Jan 202610:36 amRNSDirector/PDMR Shareholding
15th Jan 202610:35 amRNSDirector/PDMR Shareholding
15th Jan 20269:55 amRNSIssue of Equity
14th Jan 20262:39 pmRNSUnaudited NAV - Dividend Investment Scheme
13th Jan 202612:10 pmRNSUnaudited Net Asset Value
4th Dec 202510:35 amRNSSecond Interim Dividend
18th Nov 20253:48 pmRNSTransaction in Own Shares
14th Nov 20259:31 amRNSNet Asset Value(s)
13th Nov 20254:53 pmRNSResult of General Meeting
2nd Oct 20254:42 pmRNSPublication of a Prospectus
29th Aug 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSIssue of Equity
29th Aug 20257:00 amRNSHalf-year Report
20th Aug 20252:14 pmRNSStatement re Dividend Investment Scheme
31st Jul 20254:42 pmRNSTransaction in Own Shares
16th Jul 202510:18 amRNSStatement re Unaudited NAV and Interim Dividend
16th Jul 20257:08 amRNSStatement re Offer for Subscription
21st May 20254:44 pmRNSTransaction in Own Shares
16th May 20259:30 amRNSDirector/PDMR Shareholding
16th May 20259:26 amRNSIssue of Equity - Dividend Investment Scheme
9th May 20251:53 pmRNSStatement re Dividend Investment Scheme
9th May 202510:03 amRNSNet Asset Value(s)
8th May 20251:43 pmRNSResult of AGM
6th May 202511:55 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.